Novel Biomarkers In The Continuum Of Breast Cancer

April 19, 2018|
Novel Biomarkers In The Continuum Of Breast Cancer by Vered Stearns
$248.50
Paperback
Earn 1,243 plum® points
Buy Online
Ship to an address
Free shipping on orders over $35
Pick up in store
To see if pickup is available,
Buy In Store
Not sold in stores
Prices and offers may vary in store

about

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today's standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research.

Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment(s) for individual patients.

1 Genomic Biomarkers for Cancer Risk.- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.- 3 Incorporating Biomarkers in Studies of Chemoprevention.- 4 Breast Molecular Profiling and Radiotherapy Considerations.- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen R...
Loading
Title:Novel Biomarkers In The Continuum Of Breast Cancer
Format:Paperback
Product dimensions:279 pages, 23.5 X 15.5 X 0.17 in
Shipping dimensions:279 pages, 23.5 X 15.5 X 0.17 in
Published:April 19, 2018
Publisher:Springer Nature
Language:English
Appropriate for ages:All ages
ISBN - 13:9783319794341

Look for similar items by category:

Recently Viewed
|